Omar Malik
Overview
Explore the profile of Omar Malik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
El-Husseini A, Hassan W, Yaseen M, Suleiman B, Saleh S, Malik O, et al.
Transpl Infect Dis
. 2019 Mar;
21(4):e13071.
PMID: 30866136
Background: The aim of this retrospective analysis was to investigate the effect of human leukocyte antigen (HLA) and calculated panel reactive antibody (cPRA) on BK virus activation as evidenced by...
12.
Datta G, Colasanti A, Rabiner E, Gunn R, Malik O, Ciccarelli O, et al.
Brain
. 2017 Oct;
140(11):2927-2938.
PMID: 29053775
Brain magnetic resonance imaging is an important tool in the diagnosis and monitoring of multiple sclerosis patients. However, magnetic resonance imaging alone provides limited information for predicting an individual patient's...
13.
14.
Cencioni M, Magliozzi R, Nicholas R, Ali R, Malik O, Reynolds R, et al.
Immunology
. 2017 Aug;
152(4):660-676.
PMID: 28767147
Growing evidence points to a deregulated response to Epstein-Barr virus (EBV) in the central nervous system of patients with multiple sclerosis (MS) as a possible cause of disease. We have...
15.
Datta G, Colasanti A, Kalk N, Owen D, Scott G, Rabiner E, et al.
J Nucl Med
. 2017 Mar;
58(9):1477-1482.
PMID: 28302760
The objective of this study was to assess microglial activation in lesions and in normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET. Thirty-four MS patients (7 with...
16.
Raffel J, Gafson A, Dahdaleh S, Malik O, Jones B, Nicholas R
PLoS One
. 2017 Jan;
12(1):e0169546.
PMID: 28081190
Background: In people with multiple sclerosis treated with interferon-beta or glatiramer acetate, new MRI lesions and relapses during the first year of treatment predict a poor prognosis. Objective: To study...
17.
Datta G, Violante I, Scott G, Zimmerman K, Santos-Ribeiro A, Rabiner E, et al.
Mult Scler
. 2016 Dec;
23(11):1469-1478.
PMID: 27903933
Background: Multiple sclerosis (MS) is characterised by a diffuse inflammatory response mediated by microglia and astrocytes. Brain translocator protein (TSPO) positron-emission tomography (PET) and [myo-inositol] magnetic resonance spectroscopy (MRS) were...
18.
Lema A, Bishop C, Malik O, Mattoscio M, Ali R, Nicholas R, et al.
J Neuroimaging
. 2016 Aug;
27(2):221-226.
PMID: 27491693
Background: Demyelination is a core pathological feature of multiple sclerosis (MS) and spontaneous remyelination appears to be an important mechanism for repair in the disease. Magnetization transfer ratio imaging (MTR)...
19.
Singh S, Dubrey S, Malik O
Br J Hosp Med (Lond)
. 2016 Jun;
77(6):368-9.
PMID: 27269757
No abstract available.
20.
Hawkes R, Malik O, Murray A
Br J Sports Med
. 2016 May;
50(11):637-8.
PMID: 27190227
No abstract available.